CMAX Clinical Research
Adelaide, South Australia.

Link to Adelaide Trial Information

Ph. 1800 150 433

Clinical Trial AVX-001

Clinical trial AVX-001 is the first study of PVX108 to be conducted in humans.  The objectives of this trial are:

  1. to determine the maximum dose that can be safely administered as a single injection
  2. to assess the safety of repeat, escalating doses, administered once every 2 weeks.

 If you are interested in participating in this clinical trial, please contact either of the centres below:


Centre for Clinical Studies

Melbourne, Victoria.

Link to Mebourne Trial Information

Ph. 03 8593 9875